Turbocharge the Development of the Best-In-Class Kinase Inhibitor Products, to Enhance Specificity, Overcome Resistance to Deliver Safe & Durable Clinical Responses Celebrating 20 years of FDA ...

Australia's CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial year which ...

The World AI Conference 2025, which will be held in Shanghai from July 26 to 28, will see its exhibition area hit a record high of 70,000 square meters, said the conference organizer during the WAIC's ...